What is Apos®?

Apos® is an innovative, personalised and non-surgical treatment for knee , hip and lower back pain, which has been clinically proven to alleviate pain and improve mobility. Developed by doctors from the fields of orthopaedics and sports medicine, Apos® is based on established scientific principles of biomechanics and neuromuscular control. The therapy utilises an individually adjusted unique biomechanical foot-worn device and is performed as part of a patient’s day to day activities.

Instant pain relief in Apos®

Apos® are able to redistribute the forces that contribute to the pain in the joints, whilst simultaneously re-educating the brain and muscles to work more efficiently again, creating healthier walking patterns and lasting relief.

What Do the Experts Say?

What Do Patients Say?

How Easy are Apos to Use?

your Initial Assessment

The Science behind the Technology

Extensive Portfolio of research and Real-world Data


Apos® Treatment Plan

£ 1750
  • Assessment and treatment by Clinical Specialist in Apos®
  • 1 pair of individually adjusted Apos® devices
  • 12 months coverage of treatment with 3 follow up consultations
  • Digitised gait analysis and clinical outcomes tracking at each appointment
  • Personalised treatment programme
  • Adjustment of the device components according to clinical needs at the follow up consultations
  • Patient support services throughout your plan

12 month Maintenance Package

£ 400
  • 3 follow up consultations across the year
  • Digitised gait analysis and Clinical Tracking
  • Adjustments of Apos® devices and parts included
  • Review of Home Exercise Programmes and symptom management techniques

Ad hoc Follow-Up Consultation

£ 150
  • 1 follow-up consultation
  • Full review of current symptoms and adjustment of Apos® devices
  • Digitised gait analysis and clinical outcomes tracking
  • Review of Home Exercise Programmes and symptom management techniques

Frequently Asked Questions

Apos® was developed by experts in orthopaedics and sports medicine, with the aim of helping people with disabling musculoskeletal disorders – with particular focus on knee osteoarthritis. Apos® has been found to be effective for the following conditions:

  • Knee pain (Osteoarthritis, patellofemoral pain syndrome, meniscal tear, ligament tear)
  • Lower back pain
  • Rehabilitation before and after total knee and hip replacement surgery
  • Hip pain (particularly osteoarthritis)
  • Ankle problems (rehabilitation post fractures, recurrent ankle sprain)
  • Sports injury rehabilitation

Generally, Apos® treatment is not suitable for individuals who:

  • Have unexplained recurrent falls
  • Experience balance problems (that require using a walking aid indoors)
  • Suffer from severe osteoporosis

Please get in touch if you would like to discuss your condition with us

Apos® is available:

  • In-clinic (Beaulieu Community Centre, Beaulieu Square, Centenary Way, Chelmsford CM1 6AU) – BOOKINGS ONLY
  • Via Telehealth (video calls)
  • Hybrid – a mixture of the 2, dependant on need

Speak to our specialists who will be able to advise which would suit you best


WPA, Cigna, Willis Towers Watson, and The Exeter insurance companies have direct settlement arrangements for Apos® treatment. Prior to admission, you must contact your insurer to confirm that your policy covers Apos® and to receive a pre-authorisation code for the treatment.

Please note that since medical insurance is a contract between the member / patient and the insurance company, settlement of the account remains the patient’s responsibility. Our patient care team is available to answer any of your questions or queries.

Joint and muscle pain typically cause the sufferer to compensate by changing their walking patterns. Strides gets shorter, walking speed decreases, and the person avoids putting weight on the affected side. As a result, they may limp, but not necessarily in a manner that can be noticed to the untrained eye.

At your initial evaluation, a digitised gait analysis will provide an objective scientific assessment of the way you walk – including load distribution on each leg, stride length, gait symmetry and more. This, along with the rest of the assessment, enables the physiotherapist to customise the AposHealth® programme to your unique needs, and to objectively compare your progress throughout the treatment.

AposHealth® reduces pain and improves function and quality of life. The decision regarding surgery is made by the patient and their orthopaedic consultant and it is part of the AposHealth® credo not to interfere in this decision.  We discuss the expected prognosis of AposHealth® with the patients, and in some case surgical should not be delayed.

Having said that, there is growing evidence that many patients that would have otherwise had surgery have been able to delay and avoid surgery.  A recent study showed that 84% of NHS surgical candidates were able to delay surgery for at least 2 years.  Ongoing data collection supports patients 5+ years of surgical avoidance. 

The accumulated clinical global experience at Apos Medical Assets and some published and unpublished data strongly suggests that AposHealth® can (i) reduce the need for surgery significantly; and (ii) improve the outcome of surgery when AposHealth® is used as part of post-operative rehabilitation.